- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2055-7124
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mitochondria-targeting theranostics ; volume:22 ; number:1 ; day:8 ; month:11 ; year:2018 ; pages:1-14 ; date:12.2018
Biomaterials Research ; 22, Heft 1 (8.11.2018), 1-14, 12.2018
- Urheber
-
Kang, Han Chang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40824-018-0145-7
- URN
-
urn:nbn:de:101:1-2018122700394422999312
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kang, Han Chang
- SpringerLink (Online service)
Ähnliche Objekte (12)
A Mitochondria-Targeting Calcium Dye
Dual-targeting nanozyme for tumor activatable photo-chemodynamic theranostics
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
Targeting mitochondria as an anticancer strategy
Development of peptide-drug conjugates targeting mitochondria
Targeting the mitochondria in acute myeloid leukemia
Theranostics in prostaatkanker
Dual targeting of acute leukemia and supporting niche by CXCR4-directed theranostics
Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide
The ER-SURF pathway uses ER-mitochondria contact sites for protein targeting to mitochondria
Theranostics in prostate cancer
A Mitochondria-Targeting Calcium Dye
Dual-targeting nanozyme for tumor activatable photo-chemodynamic theranostics
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
Targeting mitochondria as an anticancer strategy
Development of peptide-drug conjugates targeting mitochondria
Targeting the mitochondria in acute myeloid leukemia
Theranostics in prostaatkanker
Dual targeting of acute leukemia and supporting niche by CXCR4-directed theranostics
Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide
The ER-SURF pathway uses ER-mitochondria contact sites for protein targeting to mitochondria
Theranostics in prostate cancer
A Mitochondria-Targeting Calcium Dye
Dual-targeting nanozyme for tumor activatable photo-chemodynamic theranostics
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
Targeting mitochondria as an anticancer strategy
Development of peptide-drug conjugates targeting mitochondria
Targeting the mitochondria in acute myeloid leukemia
Theranostics in prostaatkanker
Dual targeting of acute leukemia and supporting niche by CXCR4-directed theranostics
Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide
The ER-SURF pathway uses ER-mitochondria contact sites for protein targeting to mitochondria